Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12439783 | 0.92 | IGF1R (0.51) | IGF1R | |
| SCHEMBL14050386 | 0.88 | IGF1R (0.49) | IGF1RHTR6 | |
| SCHEMBL4570504 | 0.81 | IGF1R (0.78) | IGF1R | |
| SCHEMBL12438056 | 0.80 | IGF1R (0.69) | IGF1R | |
| SCHEMBL12439403 | 0.79 | IGF1R (0.49) | IGF1RHTR6 | |
| SCHEMBL12439839 | 0.77 | IGF1R (0.53) | IGF1R | |
| SCHEMBL14161970 | 0.77 | IGF1R (0.48) | IGF1R | |
| SCHEMBL14050384 | 0.76 | IGF1R (0.69) | IGF1R | |
| SCHEMBL4466156 | 0.75 | IGF1R (0.75) | IGF1R | |
| SCHEMBL15256310 | 0.74 | IGF1R (0.50) | IGF1RHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008076415-A1 | METHODS OF USING MEK INHIBITORS | EXELIXIS, INC. (US) | 2008-06-26 | — | — | WO | disclosed |